Upal Basu Roy was named vice president of research at LUNGevity Foundation.
ASCO has awarded Thomas J. Smith with its Walther Cancer Foundation Palliative and Supportive Care in Oncology Endowed Award and Lecture. Smith will accept his award and deliver a keynote address at the 2019 Supportive Care in Oncology Symposium in Oct. 25-26 in San Francisco.
ASCO announced the Health Policy Leadership Development Program Fellows for the 2019-2020 class. Wendy Allen-Rhoades of Baylor College of Medicine, and Laura LaNiel Tenner of the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, will spend the next year developing leadership skills and healthcare policy expertise.
Stephanie Dutton, UPMC Hillman Cancer Center chief operating officer and vice president, received the distinguished Susan G. Komen Greater Pennsylvania Terri L. Chapman Award.
The Northwell Health Cancer Institute announced the opening of its new Pancreatic Cancer Center, featuring a multidisciplinary team of surgical, medical and radiation oncologists, gastroenterologists, interventional radiologists, pathologists, endocrinologists, genetic counselors, social workers, nutritionists, and pain management and palliation specialists.
Otis Webb Brawley was named recipient of the 2019 AMA Distinguished Service Award by the American Medical Association board of trustees.
NCI has renewed Roswell Park Comprehensive Cancer Center's status as one of 50 Comprehensive Cancer Centers and awarded a $22.5 million Cancer Center Support Grant to fund core research and education programs.
NCI is formulating a plan to develop an innovative childhood cancer initiative focused on data sharing. The plan would be initiated with a proposed increase to NCI's budget of $50 million beginning in fiscal year 2020 and continuing, as proposed by the White House, for a total of 10 years.
The American Cancer Society and Ovarian Cancer Research Alliance partnered to fund multidisciplinary research projects to explore new ways of detecting, treating, and preventing ovarian cancer relapse and for improving quality of life among those diagnosed with ovarian cancer.
The Association of Community Cancer Centers and AstraZeneca announced a collaboration to support a national quality care initiative for patients with stage III and stage IV NSCLC.
